●
VRDN
Viridian Therapeutics, Inc.
$160K
Single buy
Discretionary Insider Activity
Date:
03/13/2023
Insiders:
Myers Scott Dunseth, director
Prior trend:
6 months of no discretionary insider activity

Summary

A $160K single buy for Viridian Therapeutics, Inc. (VRDN) on 03/13/2023 after 6 months of no discretionary insider activity.

Reports

Action Amount Date Insider Role(s) SEC Filing No
● Buy $160K 03/13/2023 Myers Scott Dunseth Director, Chief Executive Officer 0000950170-23-007570

Transactions

Action Amount Date Insider Security Type SEC Code
● Buy $160K 03/13/2023 Myers Scott Dunseth Common Stock Discretionary Purchase

Metadata

Signal ID:
p9SuxDJYKwIltshk
Detected on:
03/28/2023